JBCHEPHARM.BOJBCHEPHARM.BOBSE
Loading
Operating Expenses Over TimeExpanding
Percentile Rank86
3Y CAGR+4.9%
5Y CAGR-2.3%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+4.9%/yr
vs -2.6%/yr prior
5Y CAGR
-2.3%/yr
Recent acceleration
Acceleration
+7.5pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $6.88B | +16.4% |
| 2024 | $5.91B | +11.5% |
| 2023 | $5.30B | -11.0% |
| 2022 | $5.95B | +103.1% |
| 2021 | $2.93B | -62.0% |
| 2020 | $7.70B | +5.5% |
| 2019 | $7.31B | +10.4% |
| 2018 | $6.62B | +15.3% |
| 2017 | $5.74B | +14.6% |
| 2016 | $5.01B | - |